Motif ID Motif Logo Scanned Score Distribution Frequency of Motif Replicability Score Evolutionary Conservation Score Gene Targets Gene Ontology of CpGMM targets
CG_h9_promoter_n_RM_12_9_6 logo scan 2 0.5 2.87E-04 SUV420H1, ACSS1 histone H4-K20 trimethylation [BP],
acetate biosynthetic process [BP],
acetyl-CoA biosynthetic process from acetate [BP],
propionate biosynthetic process [BP]
CG_h9_promoter_n_RM_12_99_5 logo scan 3 0.5 2.73E-04 ASTL glutamic-type peptidase activity [MF],
cortical granule [CC]
CG_h9_promoter_n_RM_12_203_7 logo scan 4 0.75 2.95E-04 BMP4, KPNA1, IRS2, GLI3 cell differentiation involved in kidney development [BP],
cranial suture morphogenesis [BP],
mammary gland formation [BP],
thymocyte apoptotic process [BP],
dorsal/ventral neural tube patterning [BP],
mammary gland development [BP],
positive regulation of protein import into nucleus [BP]
CG_h9_promoter_n_RM_12_52_5 logo scan 4 0.5 2.41E-04 NOTCH1, AQP3, JAG2 regulation of keratinocyte differentiation [BP],
somatic stem cell division [BP],
auditory receptor cell fate commitment [BP],
Notch receptor processing [BP]
CG_h9_promoter_n_RM_14_1_2 logo scan 7 1.0 1.03E-04 TMED1, BCAP31 endoplasmic reticulum-Golgi intermediate compartment membrane [CC],
endoplasmic reticulum-Golgi intermediate compartment [CC]
CG_h9_promoter_n_RM_12_186_4 logo scan 3 0.5 1.97E-04 HYI, KIF17, HYAL2, TESC, SEC22C hydroxypyruvate isomerase activity [MF],
protein kinase inhibitor activity [MF],
receptor signaling protein tyrosine kinase inhibitor activity [MF],
protein transport [BP]
CG_h9_promoter_n_RM_12_50_2 logo scan 2 0.5 2.23E-04 OTOF, PTGIR, DLGAP3, TBX5, HOMER1, STAR cellular response to luteinizing hormone stimulus [BP],
response to nicotine [BP],
cell-cell signaling [BP],
synaptic vesicle exocytosis [BP],
cell migration involved in coronary vasculogenesis [BP]
CG_h9_promoter_n_RM_12_136_3 logo scan 2 0.5 1.74E-04 ASTL, WASL, CDK5, CNR1 regulation of nitric-oxide synthase activity [BP],
cortical granule [CC],
membrane budding [BP],
response to cocaine [BP],
synaptic transmission, glutamatergic [BP]
CG_h9_promoter_n_RM_12_172_8 logo scan 3 0.75 1.88E-04 FLII, CEP76, TLN1, HAUS4 centrosome [CC]
CG_h9_promoter_n_RM_14_20_2 logo scan 3 0.5 7.14E-04 MEX3D mRNA localization resulting in posttranscriptional regulation of gene expression [BP]
CG_h9_promoter_n_RM_12_105_2 logo scan 3 0.5 4.21E-04 EGR2 rhombomere 3 formation [BP],
rhombomere 5 formation [BP]
CG_h9_promoter_n_RM_12_97_2 logo scan 3 0.5 2.59E-04 GGH gamma-glutamyl-peptidase activity [MF]
CG_h9_promoter_n_RM_12_85_3 logo scan 2 0.5 3.77E-04 SLC6A4 negative regulation of cerebellar granule cell precursor proliferation [BP],
serotonin:sodium symporter activity [MF],
cocaine binding [MF]
CG_h9_promoter_n_RM_12_207_7 logo scan 4 0.75 3.60E-04 GRIN2C, USP4, GRIN2B, GLI3, CDK5, LHX3 N-methyl-D-aspartate selective glutamate receptor complex [CC],
cerebral cortex radial glia guided migration [BP],
regulation of excitatory postsynaptic membrane potential [BP],
ventral spinal cord interneuron specification [BP],
postsynaptic density [CC],
extracellular-glutamate-gated ion channel activity [MF],
outer membrane-bounded periplasmic space [CC],
negative regulation of protein ubiquitination [BP],
motor neuron axon guidance [BP],
spinal cord motor neuron cell fate specification [BP],
N-methyl-D-aspartate selective glutamate receptor activity [MF]
CG_h9_promoter_n_RM_12_107_11 logo scan 3 0.5 3.91E-04 ACOX1, SLC27A5 very long-chain fatty acid metabolic process [BP]
CG_h9_promoter_n_RM_12_19_5 logo scan 6 0.75 3.82E-04 ZRANB3, STK10 DNA rewinding [BP],
polo kinase kinase activity [MF]
CG_h9_promoter_n_RM_12_22_2 logo scan 2 0.5 4.64E-04 M1AP, ZRANB3, CDK5, BAZ1A DNA rewinding [BP],
male meiosis chromosome separation [BP],
ACF complex [CC],
acetylcholine receptor activator activity [MF]
CG_h9_promoter_n_RM_12_201_5 logo scan 4 0.75 3.00E-04 CD34 glomerular endothelium fenestra [CC],
negative regulation of cellular response to hypoxia [BP],
negative regulation of cellular response to heat [BP],
sulfate binding [MF],
extracellular vesicular exosome assembly [BP],
positive regulation of glial cell line-derived neurotrophic factor secretion [BP]
CG_h9_promoter_n_RM_12_196_2 logo scan 2 0.5 4.01E-04 IRX3, DLL1 negative regulation of neuron differentiation [BP],
loop of Henle development [BP],
negative regulation of auditory receptor cell differentiation [BP]
CG_h9_promoter_n_RM_12_20_8 logo scan 4 0.75 2.24E-04 PCSK7, ST6GAL2 integral to Golgi membrane [CC]
CG_h9_promoter_n_RM_12_42_4 logo scan 4 0.5 2.93E-04 NPY1R, AGTPBP1, NPC1 locomotory behavior [BP],
adult walking behavior [BP]
CG_h9_promoter_n_RM_12_188_4 logo scan 5 0.75 4.29E-04 HOXA1, ECHDC1 optokinetic behavior [BP],
abducens nerve formation [BP],
methylmalonyl-CoA decarboxylase activity [MF]
CG_h9_promoter_n_RM_12_39_6 logo scan 3 0.5 4.76E-04 FLOT2, HSPA5, ANAPC2 positive regulation of protein ubiquitination [BP],
ubiquitin protein ligase binding [MF],
endoplasmic reticulum chaperone complex [CC],
regulation of protein folding in endoplasmic reticulum [BP],
flotillin complex [CC],
cerebellum structural organization [BP]
CG_h9_promoter_n_RM_12_87_4 logo scan 4 0.75 3.27E-04 GHSR, HSPD1 growth hormone secretagogue receptor activity [MF],
positive regulation of T cell mediated immune response to tumor cell [BP],
B cell cytokine production [BP],
regulation of hindgut contraction [BP],
positive regulation of appetite [BP]
CG_h9_promoter_n_RM_12_7_5 logo scan 5 0.75 3.08E-04 NAGPA, ENTPD4, SERPINE2, GBX2 mating plug formation [BP],
cerebellum development [BP],
seminal vesicle epithelium development [BP],
UDP catabolic process [BP],
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF]
CG_h9_promoter_n_RM_12_170_4 logo scan 3 0.75 9.02E-05 DDX17 regulation of skeletal muscle cell differentiation [BP]
CG_h9_promoter_n_RM_14_9_3 logo scan 5 0.75 1.36E-04 TRMT61B mitochondrial tRNA methylation [BP]
CG_h9_promoter_n_RM_12_108_5 logo scan 2 0.5 2.80E-04 RBBP7, RLIM, SFRP4, DCTPP1, NODAL transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP],
negative regulation of sodium-dependent phosphate transport [BP],
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP],
axial mesodermal cell fate specification [BP],
pyrimidine deoxyribonucleotide binding [MF],
random inactivation of X chromosome [BP],
dCTP diphosphatase activity [MF],
cellular heat acclimation [BP],
inhibition of neuroepithelial cell differentiation [BP]
CG_h9_promoter_n_RM_12_35_4 logo scan 4 0.75 2.36E-04 NKX3-1, DDX17 positive regulation of androgen secretion [BP],
MADS box domain binding [MF],
positive regulation of response to DNA damage stimulus [BP],
estrogen receptor binding [MF]
CG_h9_promoter_n_RM_12_132_4 logo scan 4 1.0 3.39E-04 GATA2, ADAM10, TFRC, JAG2, SLC18A1, SLC8A2, NUP210, SLC25A41 constitutive protein ectodomain proteolysis [BP],
transmembrane transport [BP],
Notch receptor processing [BP],
Notch signaling pathway [BP],
negative regulation of fat cell proliferation [BP]
CG_h9_promoter_n_RM_12_89_7 logo scan 3 0.75 1.14E-04 CYP11A1, DARS cholesterol monooxygenase (side-chain-cleaving) activity [MF],
response to fungicide [BP],
aspartyl-tRNA aminoacylation [BP],
fractalkine metabolic process [BP],
aspartate-tRNA ligase activity [MF],
granulosa cell differentiation [BP],
response to genistein [BP]
CG_h9_promoter_n_RM_12_182_4 logo scan 3 0.5 4.08E-04 NFATC2, EN1, CAMK2B, DLL1, TNIP1, GDNF, SFRP2 peptidyl-serine phosphorylation [BP],
positive regulation of transcription from RNA polymerase II promoter [BP]
CG_h9_promoter_n_RM_12_25_6 logo scan 3 0.5 4.65E-04 CD34, ABCA2 lysosome [CC],
negative regulation of cellular response to hypoxia [BP],
glomerular endothelium fenestra [CC],
negative regulation of cellular response to heat [BP],
sulfate binding [MF],
extracellular vesicular exosome assembly [BP],
positive regulation of glial cell line-derived neurotrophic factor secretion [BP]
CG_h9_promoter_n_RM_12_160_4 logo scan 3 0.75 1.58E-04 WNT5A, ATG3 Atg8 ligase activity [MF],
receptor tyrosine kinase-like orphan receptor binding [MF]
CG_h9_promoter_n_RM_12_91_6 logo scan 1 0.25 5.82E-05 UBXN6, GANAB, TFAP2A cellular response to iron ion [BP],
oculomotor nerve formation [BP],
microtubule organizing center [CC],
anterior neuropore closure [BP],
optic vesicle morphogenesis [BP],
optic cup structural organization [BP],
glucosidase II complex [CC],
glucan 1,3-alpha-glucosidase activity [MF]
CG_h9_promoter_n_RM_12_130_3 logo scan 3 0.5 3.95E-04 HEY1, AKT1 atrioventricular valve formation [BP],
labyrinthine layer blood vessel development [BP],
glycogen cell differentiation involved in embryonic placenta development [BP]
CG_h9_promoter_n_RM_12_209_5 logo scan 3 0.75 2.86E-04 EZH2 cerebellar cortex development [BP]
CG_h9_promoter_n_RM_12_12_6 logo scan 2 0.5 2.93E-04 GIP, COPS2, SIX5, FGFR2, SGMS1, RNF216, BCAR1, BMP4 prostate gland morphogenesis [BP],
cell proliferation [BP],
bud elongation involved in lung branching [BP],
lung alveolus development [BP],
branching involved in prostate gland morphogenesis [BP],
regulation of smooth muscle cell differentiation [BP],
epithelial tube branching involved in lung morphogenesis [BP],
lateral sprouting from an epithelium [BP],
regulation of branching involved in prostate gland morphogenesis [BP],
cranial suture morphogenesis [BP],
digestive system development [BP],
apoptotic process [BP],
negative regulation of mitosis [BP],
epithelial cell proliferation involved in lung morphogenesis [BP],
mammary gland formation [BP],
lens development in camera-type eye [BP]
CG_h9_promoter_n_RM_14_12_5 logo scan 6 1.0 2.11E-04 SDC4, KDR, AMBP calcium oxalate binding [MF],
positive regulation of focal adhesion assembly [BP]
CG_h9_promoter_n_RM_12_103_6 logo scan 4 0.5 4.45E-04 HOXA2 rhombomere 3 morphogenesis [BP],
rhombomere 2 development [BP]
CG_h9_promoter_n_RM_12_118_5 logo scan 3 0.5 3.50E-04 TNFRSF10D, TNFRSF10B TRAIL binding [MF]
CG_h9_promoter_n_RM_12_31_6 logo scan 3 0.75 1.66E-04 DNMT3A S-adenosylhomocysteine metabolic process [BP],
DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates [MF]
CG_h9_promoter_n_RM_12_16_8 logo scan 3 0.75 2.62E-04 GANAB, TRMT61B, POU4F1, SLC5A6, SCTR, DBN1, TRPT1, CYP2J2 mitochondrial tRNA methylation [BP],
secretin receptor activity [MF],
pantothenate transmembrane transport [BP],
proprioception involved in equilibrioception [BP],
tRNA 2'-phosphotransferase activity [MF],
arachidonic acid 11,12-epoxygenase activity [MF],
biotin transport [BP],
arachidonic acid 14,15-epoxygenase activity [MF],
cell communication by chemical coupling [BP],
linoleic acid epoxygenase activity [MF],
glucosidase II complex [CC],
glucan 1,3-alpha-glucosidase activity [MF]
CG_h9_promoter_n_RM_12_66_6 logo scan 4 0.75 4.88E-04 HS6ST1, PLCD3, BSCL2, DDHD1 lipid catabolic process [BP],
labyrinthine layer blood vessel development [BP]
CG_h9_promoter_n_RM_12_176_5 logo scan 3 0.75 2.61E-04 TLN1, CDK5 cortical actin cytoskeleton organization [BP]
CG_h9_promoter_n_RM_12_54_2 logo scan 2 0.5 3.22E-04 SRXN1 sulfiredoxin activity [MF]
CG_h9_promoter_n_RM_12_101_6 logo scan 5 0.75 3.11E-04 CEBPA, NKX2-5, ADI1 transcription regulatory region DNA binding [MF],
polyamine metabolic process [BP]
CG_h9_promoter_n_RM_12_180_9 logo scan 3 0.75 2.33E-04 ESR2, NKX3-1, WNT11, ATF2, PYCARD cysteine-type endopeptidase activator activity involved in apoptotic process [MF],
regulation of intrinsic apoptotic signaling pathway [BP],
estrogen receptor activity [MF],
positive regulation of transforming growth factor beta2 production [BP]
CG_h9_promoter_n_RM_14_7_2 logo scan 5 0.75 1.68E-04 BCAT2 isoleucine catabolic process [BP]
CG_h9_promoter_n_RM_12_134_6 logo scan 2 0.5 3.10E-04 UROC1 urocanate hydratase activity [MF]
CG_h9_promoter_n_RM_12_29_3 logo scan 4 0.75 1.71E-04 CLDN19, CLDN6, CLIP3 calcium-independent cell-cell adhesion [BP],
ganglioside binding [MF]
CG_h9_promoter_n_RM_12_95_5 logo scan 2 0.5 2.71E-04 GANAB glucosidase II complex [CC],
glucan 1,3-alpha-glucosidase activity [MF]
CG_h9_promoter_n_RM_12_81_4 logo scan 5 0.75 2.53E-04 NAGPA, WT1 N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF],
negative regulation of metanephric glomerular mesangial cell proliferation [BP]
CG_h9_promoter_n_RM_12_106_5 logo scan 3 0.5 2.20E-04 FRAT2, PARK2, MAF, AKT1 multicellular organismal development [BP],
negative regulation of release of cytochrome c from mitochondria [BP],
regulation of chondrocyte differentiation [BP],
cell differentiation [BP]
CG_h9_promoter_n_RM_12_83_10 logo scan 3 0.5 3.48E-04 TXNL4A, MCL1, CAMK2B, SCTR inhibitory G-protein coupled receptor phosphorylation [BP],
secretin receptor activity [MF],
nucleoplasm [CC]
CG_h9_promoter_n_RM_12_121_3 logo scan 5 0.75 2.05E-04 SMAD2 activating transcription factor binding [MF]
CG_h9_promoter_n_RM_12_202_3 logo scan 3 0.75 2.16E-04 HEYL, TNIP1, FZD5, CSNK1D, SFRP2 AF-1 domain binding [MF],
negative regulation of dermatome development [BP],
metalloenzyme activator activity [MF],
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade [BP],
Wnt-activated receptor activity [MF],
positive regulation of canonical Wnt receptor signaling pathway [BP],
Wnt-protein binding [MF],
outflow tract morphogenesis [BP],
canonical Wnt receptor signaling pathway [BP]
CG_h9_promoter_n_RM_12_146_8 logo scan 6 0.75 3.41E-04 RACGAP1, IRS2, PPP2R2B, TIMM13, TUBGCP3, BCL6 negative regulation of B cell apoptotic process [BP],
gamma-tubulin binding [MF],
protein targeting to mitochondrion [BP]
CG_h9_promoter_n_RM_12_92_3 logo scan 2 0.5 2.11E-04 PLOD3, POLDIP3 procollagen glucosyltransferase activity [MF],
intracellular membrane-bounded organelle [CC]
CG_h9_promoter_n_RM_12_185_5 logo scan 3 0.5 4.03E-04 ADAM12, YBX2, PITX2 translation regulator activity [MF],
myoblast fusion [BP]
CG_h9_promoter_n_RM_12_139_3 logo scan 2 0.5 2.20E-04 PGGT1B, ARFGEF1, SLC4A11 phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
CAAX-protein geranylgeranyltransferase complex [CC],
borate transmembrane transporter activity [MF],
positive regulation of protein glycosylation in Golgi [BP],
borate transport [BP],
borate transmembrane transport [BP]
CG_h9_promoter_n_RM_12_98_5 logo scan 2 0.5 4.61E-04 LBX1 regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification [BP]
CG_h9_promoter_n_RM_12_58_6 logo scan 4 0.75 3.65E-04 PRICKLE1, BAZ2A heterochromatin assembly involved in chromatin silencing [BP],
negative regulation of cardiac muscle cell myoblast differentiation [BP]
CG_h9_promoter_n_RM_12_189_3 logo scan 3 0.75 2.25E-04 ESR2, AFAP1L2, STAT1, JUN, PKD1, HSPG2, RBBP7, PLA2G16, HOXA7, C1orf86, PAX3, NDNL2, BCL6, RALGAPA2, IRX2, GNL1 angiogenesis [BP],
anatomical structure morphogenesis [BP],
positive regulation of transcription, DNA-dependent [BP],
negative regulation of transcription from RNA polymerase II promoter [BP],
monocyte differentiation [BP],
renal tubule development [BP],
organ morphogenesis [BP],
regulation of transcription, DNA-dependent [BP],
negative regulation of cell-matrix adhesion [BP],
positive regulation of smooth muscle cell proliferation [BP],
sequence-specific DNA binding [MF],
negative regulation of transcription, DNA-dependent [BP],
GTP catabolic process [BP],
protein binding [MF],
chromosomal part [CC],
core promoter sequence-specific DNA binding [MF],
negative regulation of cell growth [BP],
sequence-specific DNA binding transcription factor activity [MF],
transcription from RNA polymerase II promoter [BP],
cell-matrix adhesion [BP],
nucleus [CC]
CG_h9_promoter_n_RM_12_49_5 logo scan 3 0.5 3.08E-04 HOXA5, NOTCH1, FKBP1A, JAG2 Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP],
respiratory system process [BP],
auditory receptor cell fate commitment [BP],
Notch receptor processing [BP],
ventricular cardiac muscle tissue morphogenesis [BP],
regulation of extracellular matrix assembly [BP],
heart trabecula morphogenesis [BP],
cell-cell signaling involved in mammary gland development [BP],
venous endothelial cell differentiation [BP]
CG_h9_promoter_n_RM_12_206_5 logo scan 3 0.5 2.37E-04 GAS1, FGF3, HOXA1, ALX3 embryonic skeletal system morphogenesis [BP],
optokinetic behavior [BP],
abducens nerve formation [BP],
semicircular canal morphogenesis [BP],
embryonic cranial skeleton morphogenesis [BP],
pattern specification process [BP],
outer ear morphogenesis [BP]
CG_h9_promoter_n_RM_12_10_4 logo scan 4 0.75 3.63E-04 HYAL2, GRIN2A, TFAP2A regulation of excitatory postsynaptic membrane potential [BP],
optic vesicle morphogenesis [BP],
receptor signaling protein tyrosine kinase inhibitor activity [MF],
optic cup structural organization [BP]
CG_h9_promoter_n_RM_12_70_3 logo scan 2 0.5 3.12E-04 PIGU GPI-anchor transamidase complex [CC]
CG_h9_promoter_n_RM_12_190_2 logo scan 4 0.75 3.12E-04 ZNF350, EZH2, RBBP7, TRMT61B, RENBP transcriptional repressor complex [CC],
cellular heat acclimation [BP],
mitochondrial tRNA methylation [BP],
N-acylglucosamine 2-epimerase activity [MF],
ESC/E(Z) complex [CC]
CG_h9_promoter_n_RM_12_44_4 logo scan 2 0.5 1.14E-04 CLK1, FGFR2, INSRR, SIK1, FOXA1 prostate gland morphogenesis [BP],
protein tyrosine kinase activity [MF],
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP],
fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP],
prostate gland epithelium morphogenesis [BP],
protein autophosphorylation [BP],
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP],
cellular response to alkalinity [BP],
epithelial tube branching involved in lung morphogenesis [BP],
coronal suture morphogenesis [BP]
CG_h9_promoter_n_RM_12_5_4 logo scan 2 0.5 4.57E-04 ALDH4A1, AIPL1, DACT2, COL5A3 skin development [BP],
farnesylated protein binding [MF],
1-pyrroline-5-carboxylate dehydrogenase activity [MF]
CG_h9_promoter_n_RM_12_140_3 logo scan 2 0.5 2.93E-04 NKX3-1, CDKN1C negative regulation of epithelial cell proliferation [BP],
positive regulation of androgen secretion [BP],
MADS box domain binding [MF]
CG_h9_promoter_n_RM_12_53_2 logo scan 2 0.5 3.90E-04 CRLF1 negative regulation of motor neuron apoptotic process [BP]
CG_h9_promoter_n_RM_12_200_6 logo scan 3 0.75 1.55E-04 WNT7A, NUP62, LATS2 synapse organization [BP],
hormone-mediated signaling pathway [BP]
CG_h9_promoter_n_RM_12_3_3 logo scan 3 0.5 2.54E-04 ZGLP1, ALX4, ADNP, CXCR4, BARHL2 sequence-specific DNA binding [MF],
myosin light chain binding [MF]
CG_h9_promoter_n_RM_12_72_5 logo scan 3 0.5 2.84E-04 DBR1, HNRNPR RNA splicing [BP],
RNA lariat debranching enzyme activity [MF]
CG_h9_promoter_n_RM_14_8_2 logo scan 4 0.75 5.73E-04 DBR1, NKX3-1, RUNX1 positive regulation of androgen secretion [BP],
positive regulation of progesterone secretion [BP],
MADS box domain binding [MF],
RNA lariat debranching enzyme activity [MF]
CG_h9_promoter_n_RM_12_192_7 logo scan 2 0.5 2.98E-04 TOLLIP, CELSR1, HID1 protein localization involved in establishment of planar polarity [BP],
response to brefeldin A [BP],
interleukin-18 receptor complex [CC],
extrinsic to Golgi membrane [CC]
CG_h9_promoter_n_RM_12_129_2 logo scan 3 0.75 4.31E-04 IPMK, OPRK1 inositol tetrakisphosphate 3-kinase activity [MF],
inositol-1,4,5-trisphosphate 6-kinase activity [MF],
dynorphin receptor activity [MF]
CG_h9_promoter_n_RM_12_133_4 logo scan 2 0.5 3.51E-04 SLC4A11 borate transmembrane transporter activity [MF],
borate transport [BP],
phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
borate transmembrane transport [BP]
CG_h9_promoter_n_RM_12_33_5 logo scan 2 0.5 2.81E-04 HOXA2 rhombomere 3 morphogenesis [BP],
rhombomere 2 development [BP]
CG_h9_promoter_n_RM_12_120_3 logo scan 2 0.5 4.09E-04 NAGPA, ACSS1 acetate biosynthetic process [BP],
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF],
propionate biosynthetic process [BP]
CG_h9_promoter_n_RM_12_154_4 logo scan 3 0.75 2.45E-04 FGF8, HOXB3 thyroid gland development [BP]
CG_h9_promoter_n_RM_12_41_7 logo scan 3 0.5 3.93E-04 SRCIN1, MYO10, CYGB filopodium [CC],
neuronal cell body [CC]
CG_h9_promoter_n_RM_12_73_5 logo scan 2 0.5 3.18E-04 YPEL1, HYAL2, FGF3 semicircular canal morphogenesis [BP],
regulation of myelination [BP],
negative regulation of protein kinase B signaling cascade [BP]
CG_h9_promoter_n_RM_12_195_5 logo scan 6 0.75 3.33E-04 MAFB, JAK3, CDK6, PLXNA2 cerebellar granule cell precursor tangential migration [BP],
rhombomere 6 development [BP],
negative regulation of FasL biosynthetic process [BP],
regulation of erythrocyte differentiation [BP],
cell dedifferentiation [BP]
CG_h9_promoter_n_RM_12_131_3 logo scan 3 0.75 3.25E-04 CSNK1D regulation of circadian rhythm [BP]
CG_h9_promoter_n_RM_12_197_6 logo scan 3 0.5 3.12E-04 ACD, TMEM123 oncosis [BP],
positive regulation of single-stranded telomeric DNA binding [BP]
CG_h9_promoter_n_RM_12_198_2 logo scan 3 0.5 1.83E-04 DAP cellular response to amino acid starvation [BP]
CG_h9_promoter_n_RM_12_32_4 logo scan 2 0.5 3.38E-04 SV2A, SLC30A3, HOOK2 endocytosis [BP],
synaptic vesicle membrane [CC]
CG_h9_promoter_n_RM_12_143_4 logo scan 4 0.75 1.62E-04 TEFM DNA polymerase processivity factor activity [MF]
CG_h9_promoter_n_RM_12_84_2 logo scan 4 0.75 1.17E-04 PSMD10, GPLD1, ABCB6, SLC30A1, COQ3, SUMO2 GPI anchor release [BP],
negative regulation of zinc ion transmembrane import [BP],
heme-transporting ATPase activity [MF],
2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity [MF],
cadmium ion transmembrane transport [BP],
glycosylphosphatidylinositol phospholipase D activity [MF],
positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP],
3-demethylubiquinone-9 3-O-methyltransferase activity [MF],
detoxification of cadmium ion [BP],
hexaprenyldihydroxybenzoate methyltransferase activity [MF],
cellular response to triglyceride [BP]
CG_h9_promoter_n_RM_12_34_2 logo scan 3 0.75 1.83E-04 PTGR1, BCAT1, NANP branched-chain amino acid biosynthetic process [BP],
N-acylneuraminate-9-phosphatase activity [MF],
2-alkenal reductase [NAD(P)] activity [MF],
N-acetylneuraminate biosynthetic process [BP],
N-acetylglucosamine biosynthetic process [BP]
CG_h9_promoter_n_RM_12_116_8 logo scan 4 1.0 5.31E-04 HOXB5, HOXB3 embryonic skeletal system morphogenesis [BP],
rhombomere development [BP]
CG_h9_promoter_n_RM_12_156_5 logo scan 3 0.75 3.68E-04 FGFR2 negative regulation of mitosis [BP]
CG_h9_promoter_n_RM_12_45_5 logo scan 2 0.5 4.80E-04 FKBP1A peptidyl-proline modification [BP]
CG_h9_promoter_n_RM_14_6_2 logo scan 3 0.75 5.90E-04 HYAL1 hyaluranon cable [CC]
CG_h9_promoter_n_RM_12_78_2 logo scan 3 0.75 1.88E-04 KDSR, LDB1, LHX5, EPHA4 DH domain binding [MF],
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP],
3-dehydrosphinganine reductase activity [MF],
cerebellar Purkinje cell differentiation [BP],
3-keto-sphinganine metabolic process [BP],
sphingolipid biosynthetic process [BP],
histone H3-K4 acetylation [BP],
positive regulation of Rho guanyl-nucleotide exchange factor activity [BP]
CG_h9_promoter_n_RM_12_64_4 logo scan 3 0.5 2.68E-04 MYO1C, FH fumarate hydratase activity [MF],
myosin I complex [CC],
positive regulation of vascular endothelial growth factor signaling pathway [BP]
CG_h9_promoter_n_RM_12_96_8 logo scan 4 0.75 3.08E-04 AMPH, IPMK, CCT4, NADKD1, DVL1, BRAF, PLCD3, MAPK1, ILF2, TOR2A, CDK5, CNR1 synaptic transmission [BP],
synaptic vesicle endocytosis [BP],
response to epidermal growth factor stimulus [BP],
peptidyl-serine phosphorylation [BP],
sensory perception of pain [BP],
receptor clustering [BP],
labyrinthine layer blood vessel development [BP],
ATP binding [MF]
CG_h9_promoter_n_RM_12_30_3 logo scan 2 0.5 4.32E-04 VGF response to cold [BP]
CG_h9_promoter_n_RM_12_183_4 logo scan 2 0.5 2.15E-04 TBX5, SURF6 nucleoplasm part [CC],
cell migration involved in coronary vasculogenesis [BP]
CG_h9_promoter_n_RM_12_199_2 logo scan 2 0.5 3.25E-04 RORA cGMP metabolic process [BP]
CG_h9_promoter_n_RM_12_137_4 logo scan 3 0.5 4.62E-04 PEMT phosphatidylethanolamine N-methyltransferase activity [MF],
phosphatidyl-N-dimethylethanolamine N-methyltransferase activity [MF],
phosphatidyl-N-methylethanolamine N-methyltransferase activity [MF]
CG_h9_promoter_n_RM_12_94_3 logo scan 3 0.75 3.41E-04 GLRX2, CALCR arsenate reductase (glutaredoxin) activity [MF],
calcitonin binding [MF]
CG_h9_promoter_n_RM_14_15_2 logo scan 4 0.5 3.29E-04 MTHFSD, PRKCQ 5-formyltetrahydrofolate cyclo-ligase activity [MF],
positive regulation of T-helper 2 cell activation [BP]
CG_h9_promoter_n_RM_12_48_4 logo scan 3 0.5 3.83E-04 TBX20, APIP, SHANK1, STAT1, SHH patterning of blood vessels [BP],
somatostatin receptor binding [MF],
methylthioribulose 1-phosphate dehydratase activity [MF],
metanephric mesenchymal cell proliferation involved in metanephros development [BP],
positive regulation of mesenchymal cell proliferation [BP],
heart looping [BP],
pattern specification process [BP]
CG_h9_promoter_n_RM_12_181_2 logo scan 3 0.75 2.02E-04 MYO10, RBBP7 cellular heat acclimation [BP],
plus-end directed microfilament motor activity [MF]
CG_h9_promoter_n_RM_12_102_3 logo scan 3 0.5 3.38E-04 VAV2, DTYMK, CDK5, HAND2, GAS1, MYH10 embryonic digit morphogenesis [BP],
adult heart development [BP],
nucleoside monophosphate phosphorylation [BP],
cerebellum morphogenesis [BP],
cell migration [BP],
axon guidance [BP],
nucleoside phosphate kinase activity [MF],
neuromuscular junction [CC],
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis [BP],
acetylcholine receptor activator activity [MF],
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process [BP]
CG_h9_promoter_n_RM_12_55_2 logo scan 3 0.5 3.86E-04 HOXA5, TNS3 cell-cell signaling involved in mammary gland development [BP],
lung alveolus development [BP]
CG_h9_promoter_n_RM_12_152_3 logo scan 2 0.5 1.77E-04 NUMBL, SHH CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [BP],
neuroblast proliferation [BP],
intein-mediated protein splicing [BP],
right lung development [BP],
mesenchymal smoothened signaling pathway involved in prostate gland development [BP],
regulation of mesenchymal cell proliferation involved in prostate gland development [BP],
neuroblast division in subventricular zone [BP],
positive regulation of skeletal muscle cell proliferation [BP],
negative regulation of kidney smooth muscle cell differentiation [BP],
positive regulation of epithelial cell proliferation involved in prostate gland development [BP],
epithelial-mesenchymal signaling involved in prostate gland development [BP],
negative regulation of ureter smooth muscle cell differentiation [BP],
primary prostatic bud elongation [BP],
positive regulation of kidney smooth muscle cell differentiation [BP],
positive regulation of ureter smooth muscle cell differentiation [BP],
positive regulation of sclerotome development [BP],
multicellular structure septum development [BP]
CG_h9_promoter_n_RM_12_59_3 logo scan 3 0.5 1.96E-04 SRD5A2, WT1 sterol 5-alpha reductase activity [MF],
negative regulation of metanephric glomerular mesangial cell proliferation [BP]
CG_h9_promoter_n_RM_12_168_4 logo scan 3 0.75 3.68E-04 RUNX1, GPLD1, MMS22L, UBE2N, RECQL4 DNA recombination [BP],
GPI anchor release [BP],
cellular response to triglyceride [BP],
double-strand break repair via homologous recombination [BP],
positive regulation of progesterone secretion [BP],
glycosylphosphatidylinositol phospholipase D activity [MF]
CG_h9_promoter_n_RM_12_204_6 logo scan 3 0.5 2.98E-04 PLXNB1, HOMER1 semaphorin-plexin signaling pathway [BP],
regulation of calcium ion import [BP]
CG_h9_promoter_n_RM_12_147_6 logo scan 3 0.75 2.58E-04 NACA negative regulation of transcription from RNA polymerase II promoter involved in heart development [BP],
nascent polypeptide-associated complex [CC]
CG_h9_promoter_n_RM_12_43_5 logo scan 3 0.5 2.33E-04 LSM4 U6 snRNP [CC]
CG_h9_promoter_n_RM_12_194_4 logo scan 6 0.75 1.23E-04 UROC1 urocanate hydratase activity [MF]
CG_h9_promoter_n_RM_12_145_2 logo scan 4 0.75 4.20E-04 AMOTL2, AXIN2, HSPA5, NKX2-5, STX8 proepicardium development [BP],
Wnt receptor signaling pathway [BP],
ubiquitin protein ligase binding [MF],
positive regulation of voltage-gated calcium channel activity [BP],
Purkinje myocyte differentiation [BP],
regulation of protein folding in endoplasmic reticulum [BP],
atrioventricular node cell fate commitment [BP],
regulation of chondrocyte development [BP]
CG_h9_promoter_n_RM_12_82_4 logo scan 5 0.75 4.59E-04 TNK2, ERBB4, MAD1L1 epidermal growth factor receptor binding [MF],
mitotic telophase [BP],
cardiac muscle tissue regeneration [BP]
CG_h9_promoter_n_RM_12_76_5 logo scan 2 0.5 2.31E-04 ANKLE2, TGFB1 positive regulation of protein dephosphorylation [BP],
lens fiber cell differentiation [BP]
CG_h9_promoter_n_RM_12_149_4 logo scan 4 0.75 1.51E-04 SIN3A, TXNRD2 response to methylglyoxal [BP],
response to oxygen radical [BP],
negative regulation of histone H3-K27 acetylation [BP]
CG_h9_promoter_n_RM_12_110_4 logo scan 5 0.75 2.26E-04 FASN, FBXW5, DCAF5, ANKLE2 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF],
3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF],
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF],
[acyl-carrier-protein] S-acetyltransferase activity [MF],
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF],
Cul4-RING ubiquitin ligase complex [CC],
mitotic nuclear envelope reassembly [BP]
CG_h9_promoter_n_RM_12_2_3 logo scan 4 0.5 1.92E-04 JUP, GEM, BVES epithelial cell-cell adhesion [BP],
internal side of plasma membrane [CC],
lateral plasma membrane [CC]
CG_h9_promoter_n_RM_12_208_3 logo scan 2 0.5 2.50E-04 EZH2 chromatin organization [BP],
histone methyltransferase activity [MF],
pronucleus [CC],
histone-lysine N-methyltransferase activity [MF]
CG_h9_promoter_n_RM_12_36_2 logo scan 3 0.5 4.75E-04 MEX3D, LSS, SNAI2 desmosome disassembly [BP],
mRNA localization resulting in posttranscriptional regulation of gene expression [BP],
negative regulation of stem cell proliferation [BP],
lanosterol synthase activity [MF],
negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter [BP],
negative regulation of vitamin D receptor signaling pathway [BP]
CG_h9_promoter_n_RM_14_21_6 logo scan 5 0.5 3.33E-04 PFN2 regulation of synaptic vesicle exocytosis [BP]
CG_h9_promoter_n_RM_12_68_6 logo scan 2 0.5 3.97E-04 VPS53, OCA2, ALG5, ALG2 dolichol-linked oligosaccharide biosynthetic process [BP],
endosome membrane [CC]
CG_h9_promoter_n_RM_12_112_2 logo scan 4 0.5 2.86E-04 AMBP calcium oxalate binding [MF]
CG_h9_promoter_n_RM_12_88_5 logo scan 3 0.75 2.08E-04 SMARCA1 helicase activity [MF],
ATP-dependent chromatin remodeling [BP]
CG_h9_promoter_n_RM_12_74_3 logo scan 2 0.5 2.01E-04 FOXA2, TPT1, FGF8, CITED1 response to interleukin-11 [BP],
cell migration involved in mesendoderm migration [BP],
response to interleukin-6 [BP],
regulation of transcription from RNA polymerase II promoter involved in detection of glucose [BP],
embryonic axis specification [BP],
endoderm development [BP],
branching involved in ureteric bud morphogenesis [BP],
dopaminergic neuron differentiation [BP],
signal transduction involved in regulation of gene expression [BP],
negative regulation of detection of glucose [BP],
negative regulation of transcription from RNA polymerase II promoter by glucose [BP],
negative regulation of ectoderm development [BP],
lung morphogenesis [BP]
CG_h9_promoter_n_RM_12_38_4 logo scan 3 0.5 3.80E-04 WNT10B, CHRM4, PLOD3 positive regulation of anagen [BP],
procollagen glucosyltransferase activity [MF],
procollagen galactosyltransferase activity [MF],
procollagen-lysine 5-dioxygenase activity [MF],
myoblast cell differentiation involved in skeletal muscle regeneration [BP],
basement membrane assembly [BP],
neural tube development [BP],
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway [BP]
CG_h9_promoter_n_RM_12_193_8 logo scan 6 0.75 3.19E-04 HOXA1 motor neuron axon guidance [BP]
CG_h9_promoter_n_RM_12_205_11 logo scan 4 0.75 2.01E-04 PPP3CA, ANKLE2, SLC5A6, XBP1, LSM4 biotin transport [BP],
epithelial cell maturation involved in salivary gland development [BP],
pantothenate transmembrane transport [BP],
mitotic nuclear envelope reassembly [BP],
serotonin secretion, neurotransmission [BP],
U6 snRNP [CC],
transition between fast and slow fiber [BP]
CG_h9_promoter_n_RM_12_60_3 logo scan 2 0.5 3.37E-04 AXIN2 regulation of chondrocyte development [BP]
CG_h9_promoter_n_RM_12_155_2 logo scan 2 0.5 2.28E-04 ANXA7 nuclear envelope [CC]
CG_h9_promoter_n_RM_12_141_4 logo scan 3 0.75 2.83E-04 TRMT61B, NOTCH1, CARD9, SNTA1 response to muramyl dipeptide [BP],
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP],
regulation of extracellular matrix assembly [BP],
mitochondrial tRNA methylation [BP],
venous endothelial cell differentiation [BP],
regulation of vasoconstriction by circulating norepinephrine [BP]
CG_h9_promoter_n_RM_12_23_3 logo scan 3 0.75 1.71E-04 CD34, SLC22A6 glomerular endothelium fenestra [CC],
renal tubular secretion [BP],
negative regulation of cellular response to hypoxia [BP],
negative regulation of cellular response to heat [BP],
sulfate binding [MF],
extracellular vesicular exosome assembly [BP],
positive regulation of glial cell line-derived neurotrophic factor secretion [BP]
CG_h9_promoter_n_RM_12_46_4 logo scan 3 0.5 2.72E-04 CSNK1D, PRICKLE1 positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP]
CG_h9_promoter_n_RM_14_17_1 logo scan 2 0.5 3.36E-04 HOXA5, OCA2, ALG2 GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [MF],
arsenite transmembrane transporter activity [MF],
protein glycosylation in endoplasmic reticulum [BP],
L-tyrosine transmembrane transporter activity [MF],
cell-cell signaling involved in mammary gland development [BP],
arsenite transport [BP],
tyrosine transport [BP]
CG_h9_promoter_n_RM_12_79_3 logo scan 2 0.5 3.12E-04 STRA13, TONSL replication fork processing [BP]
CG_h9_promoter_n_RM_12_122_7 logo scan 2 0.5 3.46E-04 DLL1, NOTCH1, NDN, RACGAP1 left/right axis specification [BP],
compartment pattern specification [BP],
neuronal stem cell maintenance [BP],
Notch receptor processing [BP],
gamma-tubulin binding [MF]
CG_h9_promoter_n_RM_12_67_7 logo scan 3 0.75 2.65E-04 HOXA5 positive regulation of receptor biosynthetic process [BP]
CG_h9_promoter_n_RM_12_153_4 logo scan 2 0.5 2.95E-04 FBXO5, NEK2 spindle assembly involved in female meiosis I [BP],
regulation of mitosis [BP],
spindle assembly [BP],
inhibition of mitotic anaphase-promoting complex activity [BP]
CG_h9_promoter_n_RM_14_19_1 logo scan 2 0.5 6.69E-04 TSC1 rRNA export from nucleus [BP],
TSC1-TSC2 complex [CC]
CG_h9_promoter_n_RM_12_178_7 logo scan 6 0.75 3.40E-04 SMAD7, BCAR1, PCID2, GLI3 anterior semicircular canal development [BP],
lambdoid suture morphogenesis [BP],
lateral ganglionic eminence cell proliferation [BP],
regulation of apoptotic process [BP],
lateral semicircular canal development [BP],
sagittal suture morphogenesis [BP],
beta-catenin binding [MF],
negative regulation of apoptotic process [BP],
artery development [BP]
CG_h9_promoter_n_RM_12_124_3 logo scan 3 0.5 4.99E-04 CDKN2A, SMAD7, FGFR2, KIAA0368, NACC2 somatic stem cell division [BP],
ventricular septum morphogenesis [BP],
ventricular cardiac muscle tissue morphogenesis [BP],
endoplasmic reticulum [CC],
posttranscriptional regulation of gene expression [BP],
negative regulation of mitosis [BP],
cellular protein complex localization [BP]
CG_h9_promoter_n_RM_12_77_4 logo scan 3 0.5 3.38E-04 HDAC3, WNT10B, RANGAP1, NOTCH1, E2F8, ABCA2, ATF6B, KCTD1, SLC4A11 regulation of extracellular matrix assembly [BP],
positive regulation of anagen [BP],
phosphoenolpyruvate-dependent sugar phosphotransferase system [BP],
Ran GTPase activator activity [MF],
transcription corepressor activity [MF],
negative regulation of transcription from RNA polymerase II promoter [BP],
myoblast cell differentiation involved in skeletal muscle regeneration [BP],
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [BP],
chromatin DNA binding [MF],
anagen [BP],
sprouting angiogenesis [BP],
transcription, DNA-dependent [BP],
negative regulation of transcription, DNA-dependent [BP],
positive regulation of Ran GTPase activity [BP],
borate transmembrane transporter activity [MF],
cell cycle comprising mitosis without cytokinesis [BP],
venous endothelial cell differentiation [BP],
positive regulation of epithelial cell differentiation [BP],
borate transport [BP],
borate transmembrane transport [BP],
regulation of transcription from RNA polymerase II promoter [BP]
CG_h9_promoter_n_RM_12_177_6 logo scan 3 0.5 3.51E-04 HOXA5 cell-cell signaling involved in mammary gland development [BP]
CG_h9_promoter_n_RM_12_86_10 logo scan 4 0.75 2.20E-04 MGEA5, MMS19, NEUROD2 negative regulation of cardiac muscle adaptation [BP],
cerebellar cortex development [BP],
phosphorelay signal transduction system [BP]
CG_h9_promoter_n_RM_12_71_4 logo scan 3 0.75 2.17E-04 UGDH, GCH1, IL6ST, MOCS1, NACC2, EIF2B1, HIBCH, EEF2, RAB27A interleukin-11 binding [MF],
GTP binding [MF],
UDP-glucose 6-dehydrogenase activity [MF],
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter [BP],
GDP binding [MF],
secretory granule membrane [CC],
ciliary neurotrophic factor receptor complex [CC],
negative regulation of interleukin-6-mediated signaling pathway [BP],
cytotoxic T cell degranulation [BP],
3-hydroxyisobutyryl-CoA hydrolase activity [MF],
interleukin-11 receptor activity [MF],
GTP cyclohydrolase I activity [MF],
7,8-dihydroneopterin 3'-triphosphate biosynthetic process [BP],
interleukin-27-mediated signaling pathway [BP]
CG_h9_promoter_n_RM_12_175_2 logo scan 2 0.5 3.00E-04 NUDT18, MED1, VDR, TAF12 retinoic acid receptor binding [MF],
GDP catabolic process [BP],
DNA-dependent transcription, initiation [BP],
8-oxo-GDP phosphatase activity [MF],
8-oxo-dGDP phosphatase activity [MF],
vitamin D3 receptor activity [MF],
transcription initiation from RNA polymerase II promoter [BP],
negative regulation of keratinocyte proliferation [BP],
dADP catabolic process [BP],
dGDP catabolic process [BP],
vitamin D receptor signaling pathway [BP],
8-hydroxy-dADP phosphatase activity [MF],
positive regulation of keratinocyte differentiation [BP]
CG_h9_promoter_n_RM_12_167_4 logo scan 5 0.75 3.09E-04 RUNX1, ALX4, CEBPA positive regulation of progesterone secretion [BP],
response to vitamin B2 [BP],
HMG box domain binding [MF]
CG_h9_promoter_n_RM_12_18_5 logo scan 4 0.75 4.90E-04 DEGS2, DLG4, LPHN1 P2Y1 nucleotide receptor binding [MF],
sphingolipid delta-4 desaturase activity [MF],
sphingosine hydroxylase activity [MF],
axon [CC]
CG_h9_promoter_n_RM_12_26_4 logo scan 4 0.5 3.65E-04 PGF, RUNX1, CD34, DTYMK, TWIST1 glomerular endothelium fenestra [CC],
negative regulation of cellular response to hypoxia [BP],
nucleoside monophosphate phosphorylation [BP],
extracellular vesicular exosome assembly [BP],
sulfate binding [MF],
positive regulation of progesterone secretion [BP],
positive regulation of angiogenesis [BP],
negative regulation of tumor necrosis factor production [BP],
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation [BP],
nucleoside phosphate kinase activity [MF],
hematopoietic stem cell proliferation [BP],
negative regulation of cellular response to heat [BP],
cell proliferation involved in heart valve development [BP],
positive regulation of glial cell line-derived neurotrophic factor secretion [BP]
CG_h9_promoter_n_RM_12_90_3 logo scan 2 0.5 1.42E-04 RAB38 phagosome acidification [BP]
CG_h9_promoter_n_RM_12_161_5 logo scan 3 0.75 2.42E-04 PAX6, PDGFA regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [BP],
salivary gland morphogenesis [BP],
commitment of neuronal cell to specific neuron type in forebrain [BP],
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment [BP],
pancreatic A cell development [BP],
forebrain-midbrain boundary formation [BP]
CG_h9_promoter_n_RM_12_75_8 logo scan 6 0.75 3.28E-04 PTK2, RGS7, GNAQ, AKT1 positive regulation of blood vessel endothelial cell migration [BP],
endothelial cell migration [BP],
osteoblast differentiation [BP],
fat cell differentiation [BP],
regulation of endothelial cell migration [BP],
heterotrimeric G-protein complex [CC],
regulation of action potential [BP]
CG_h9_promoter_n_RM_12_115_9 logo scan 4 0.75 4.54E-04 HOXB3, GNA13, SLC4A7, GBX2, PLXND1 patterning of blood vessels [BP],
retinal cell programmed cell death [BP],
rhombomere development [BP]
CG_h9_promoter_n_RM_12_104_2 logo scan 3 0.5 3.18E-04 CEBPA, SH3YL1, C2CD5, P2RX1 external side of cell outer membrane [CC],
response to vitamin B2 [BP],
ruffle membrane [CC]
CG_h9_promoter_n_RM_14_22_7 logo scan 5 0.5 3.61E-04 TAF12, EDF1 transcription factor TFIID complex [CC]
CG_h9_promoter_n_RM_12_13_4 logo scan 4 0.75 3.96E-04 CCNE2 cyclin-dependent protein kinase regulator activity [MF]
CG_h9_promoter_n_RM_12_211_2 logo scan 3 0.75 2.49E-04 RNF168, ABO, MGAT1 fucosylgalactoside 3-alpha-galactosyltransferase activity [MF],
histone H2A-K15 ubiquitination [BP],
glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity [MF],
alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF],
histone H2A-K13 ubiquitination [BP],
UDP-N-acetylglucosamine catabolic process [BP]
CG_h9_promoter_n_RM_12_109_7 logo scan 4 0.75 5.97E-04 GLRX2, OCA2, MTFMT DNA protection [BP],
L-tyrosine transmembrane transporter activity [MF],
arsenate reductase (glutaredoxin) activity [MF],
arsenite transport [BP],
methionyl-tRNA formyltransferase activity [MF],
tyrosine transport [BP]
CG_h9_promoter_n_RM_12_164_3 logo scan 3 0.5 2.18E-04 NAGPA, INPP5K, IP6K1, BCOR, PITX2 positive regulation of renal water transport [BP],
phosphatidylinositol phosphorylation [BP],
negative regulation of histone H3-K36 methylation [BP],
prolactin secreting cell differentiation [BP],
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [MF],
subthalamic nucleus development [BP],
superior vena cava morphogenesis [BP]
CG_h9_promoter_n_RM_12_11_4 logo scan 2 0.5 2.28E-05 SHOX2 positive regulation of skeletal muscle fiber development [BP],
regulation of branching morphogenesis of a nerve [BP]
CG_h9_promoter_n_RM_12_24_6 logo scan 2 0.5 3.07E-04 SCML2 PcG protein complex [CC]
CG_h9_promoter_n_RM_12_28_5 logo scan 2 0.5 2.58E-04 KIAA0368, VCP ER-associated protein catabolic process [BP]
CG_h9_promoter_n_RM_12_17_3 logo scan 3 0.5 2.04E-04 SRXN1, UGGT2, GLRX2, FASN 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity [MF],
oxidoreductase activity, acting on a sulfur group of donors [MF],
sulfiredoxin activity [MF],
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity [MF],
[acyl-carrier-protein] S-acetyltransferase activity [MF],
UDP-glucosylation [BP],
3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [MF],
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [MF],
arsenate reductase (glutaredoxin) activity [MF]
CG_h9_promoter_n_RM_12_179_4 logo scan 2 0.5 2.29E-04 FGFR2, HDDC3, ALX4, CD59 negative regulation of activation of membrane attack complex [BP],
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [BP],
guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [MF],
fibroblast growth factor receptor signaling pathway involved in hemopoiesis [BP],
regulation of apoptotic process [BP],
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow [BP],
coronal suture morphogenesis [BP]
CG_h9_promoter_n_RM_12_63_6 logo scan 2 0.5 3.00E-04 GIPC1 myosin binding [MF]
CG_h9_promoter_n_RM_12_37_4 logo scan 2 0.5 2.64E-04 STK10, NKX3-1, COQ2, TFAP2A 4-hydroxybenzoate decaprenyltransferase activity [MF],
core promoter binding [MF],
MADS box domain binding [MF],
salivary gland development [BP],
polo kinase kinase activity [MF],
optic cup structural organization [BP],
positive regulation of androgen secretion [BP],
optic vesicle morphogenesis [BP],
4-hydroxybenzoate nonaprenyltransferase activity [MF],
negative regulation of mitotic cell cycle [BP]
CG_h9_promoter_n_RM_12_15_6 logo scan 4 1.0 2.66E-04 TOB1, CEBPD, COPS2, THRB, DEAF1, NOTCH1, SOX21 negative regulation of BMP signaling pathway [BP],
chromatin DNA binding [MF],
negative regulation of osteoblast differentiation [BP],
transcription from RNA polymerase II promoter [BP],
regulation of transcription from RNA polymerase II promoter [BP]
CG_h9_promoter_n_RM_12_171_6 logo scan 3 0.5 5.47E-04 ZFHX3, POLR2E transcription from RNA polymerase II promoter [BP]
CG_h9_promoter_n_RM_14_11_3 logo scan 3 0.75 9.74E-05 ADAM8 positive regulation of fibronectin-dependent thymocyte migration [BP],
alpha9-beta1 integrin-ADAM8 complex [CC],
positive regulation of eosinophil migration [BP],
positive regulation of neutrophil extravasation [BP],
dense core granule membrane [CC]
CG_h9_promoter_n_RM_14_16_1 logo scan 4 0.5 3.49E-04 MCL1 protein channel activity [MF]